Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer

NCT06441565 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Fruquintinib
DRUG: Fluorouracil
DRUG: Oxaliplatin

Sponsor

Sun Yat-sen University